Thomas Reiner PhD

Tom Reiner serves as the Chief Scientific Officer at Evergreen Theragnostics.

He is the former Radioligand Therapy (RLT) Lead at the Novartis Institutes for Biomedical Research (NIBR) and a former member of the NIBR Oncology Leadership Team. Dr. Reiner also served as Head of RLT Drug Discovery on the AAA/Novartis Executive Leadership Team.

During his academic career, he was an Assistant/Associate Member and Laboratory Head at Memorial Sloan Kettering Cancer Center. He was also a Member of the Sloan Kettering Institute Chemical Biology Program from 2018 to 2021. He is the recipient of the 2020 WMIS Roger Tsien Award for Excellence in Chemical Biology.

From 2009 to 2012, Tom served as a Postdoc and Instructor at Harvard Medical School/Massachusetts General Hospital. Tom received his Ph.D. from the Technical University of Munich, Germany, where he trained as a synthetic chemist.